4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDER OG 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDER SOM BTK-INHIBITORER

The present invention relates to 6-5 membered fused pyridine ring compounds according to formula Ior a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 mem...

Full description

Saved in:
Bibliographic Details
Main Authors JANS, Christiaan, Gerardus, Johannes, Maria, OUBRIE, Arthur A, STERRENBURG, Jan-Gerard, RAAIJMAKERS, Hans C.A, WIJKMANS, Jacobus C.H.M, BARF, Tjeerd A, MAN, de Adrianus, Petrus, Antonius, REWINKEL, Johannes, Bernardus, Maria
Format Patent
LanguageDanish
Published 18.02.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to 6-5 membered fused pyridine ring compounds according to formula Ior a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds according to formula I in the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.
Bibliography:Application Number: DK20120733505T